Business Description
KNC Laboratories Co Ltd
ISIN : JP3290400005
Share Class Description:
TSE:6568: Ordinary SharesCompare
Compare
Traded in other countries / regions
6568.Japan IPO Date
2018-03-15Description
KNC Laboratories Co Ltd is an organic chemical and biochemical manufacturing company.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.02 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 0.94 | |||||
| Interest Coverage | 222.18 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.03 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.1 | |||||
| 3-Year EBITDA Growth Rate | 25.6 | |||||
| 3-Year EPS without NRI Growth Rate | 47.8 | |||||
| 3-Year FCF Growth Rate | 25.3 | |||||
| 3-Year Book Growth Rate | 9.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.43 | |||||
| 9-Day RSI | 29.21 | |||||
| 14-Day RSI | 35.43 | |||||
| 6-1 Month Momentum % | -11.94 | |||||
| 12-1 Month Momentum % | -17.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | |||||
| Quick Ratio | 2.29 | |||||
| Cash Ratio | 1.29 | |||||
| Days Inventory | 186.91 | |||||
| Days Sales Outstanding | 59.04 | |||||
| Days Payable | 18.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.89 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| 3-Year Dividend Growth Rate | 6.3 | |||||
| Forward Dividend Yield % | 3.17 | |||||
| 5-Year Yield-on-Cost % | 3.44 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | -8.27 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36 | |||||
| Operating Margin % | 22.74 | |||||
| Net Margin % | 16.31 | |||||
| FCF Margin % | 9.29 | |||||
| ROE % | 11.87 | |||||
| ROA % | 8.99 | |||||
| ROIC % | 11.27 | |||||
| ROC (Joel Greenblatt) % | 18.61 | |||||
| ROCE % | 14.48 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.56 | |||||
| PE Ratio without NRI | 5.55 | |||||
| Price-to-Owner-Earnings | 3.77 | |||||
| PEG Ratio | 0.43 | |||||
| PS Ratio | 0.9 | |||||
| PB Ratio | 0.64 | |||||
| Price-to-Tangible-Book | 0.64 | |||||
| Price-to-Free-Cash-Flow | 9.76 | |||||
| Price-to-Operating-Cash-Flow | 2.58 | |||||
| EV-to-EBIT | 3.94 | |||||
| EV-to-EBITDA | 3.94 | |||||
| EV-to-Revenue | 0.9 | |||||
| EV-to-FCF | 9.72 | |||||
| Price-to-Projected-FCF | 0.72 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.32 | |||||
| Price-to-Graham-Number | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 3.51 | |||||
| Earnings Yield (Greenblatt) % | 25.4 | |||||
| FCF Yield % | 10.23 | |||||
| Forward Rate of Return (Yacktman) % | 11.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KNC Laboratories Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 9,154.577 | ||
| EPS (TTM) (円) | 193.458 | ||
| Beta | 0.5 | ||
| Volatility % | 18.27 | ||
| 14-Day RSI | 35.43 | ||
| 14-Day ATR (円) | 21.771094 | ||
| 20-Day SMA (円) | 1108.8 | ||
| 12-1 Month Momentum % | -17.86 | ||
| 52-Week Range (円) | 977 - 1533 | ||
| Shares Outstanding (Mil) | 7.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KNC Laboratories Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KNC Laboratories Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
KNC Laboratories Co Ltd Frequently Asked Questions
What is KNC Laboratories Co Ltd(TSE:6568)'s stock price today?
The current price of TSE:6568 is 円1075.00. The 52 week high of TSE:6568 is 円1533.00 and 52 week low is 円977.00.
When is next earnings date of KNC Laboratories Co Ltd(TSE:6568)?
The next earnings date of KNC Laboratories Co Ltd(TSE:6568) is .
Does KNC Laboratories Co Ltd(TSE:6568) pay dividends? If so, how much?
The Dividend Yield %  of KNC Laboratories Co Ltd(TSE:6568) is 2.89% (As of Today), Highest Dividend Payout Ratio of KNC Laboratories Co Ltd(TSE:6568) was 1113.13. The lowest was 0.08. And the median was 0.25. The  Forward Dividend Yield % of KNC Laboratories Co Ltd(TSE:6568) is 3.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers